Clinical Trials Browser

INDUSTRY × Observational × Breast × Clear all

NCT06428799 2026-03-18

EMBLEDDA-MMG

Breast Neoplasms

NCT06833853 2026-03-18

CTC-EXPRESS

Breast Neoplasms

NCT05662345 2026-03-17

ACT-MBC

Active not recruiting

Breast Neoplasms

NCT07476170 2026-03-17

Real-World Treatment Pattern and Clinical Outcome With Influential Factors of HR+/HER2-aBC 1L Patients in China

Not yet recruiting

14,000 enrolled

Breast Neoplasms

NCT05697146 2026-03-16

RosaLEE

Active not recruiting

Breast Neoplasms

NCT06610539 2026-03-16

MAGProm

Breast Neoplasms

NCT06930859 2026-03-16

ELEGANCE

Breast Neoplasms

NCT05677308 2026-03-13

LYNPARZA Breast Cancer in the Adjuvant Setting Japan Post-Marketing Surveillance (PMS)

Breast Neoplasms

NCT07219277 2026-03-11

Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening

Breast Neoplasms

NCT07459062 2026-03-09

SPCTR-I

Breast Neoplasms

NCT07211178 2026-03-04

GEMINI Breast

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT06830720 2026-03-03

CAROLEEN

Breast Neoplasms

NCT04498481 2026-02-27

TREATMENT AND MONITORING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS RECEIVING PALBOCICLIB COMBINATION TREATMENT (WITH AI OR FULVESTRANT) FOR HR+/HER2- A/MBC IN A COMMUNITY ONCOLOGY SETTING.

Breast Neoplasms

NCT05573893 2026-02-27

PROVIDENCE

Breast Neoplasms, Neoplasm Metastasis

NCT07070128 2026-02-24

STAR-BREAST

Breast Neoplasms

NCT07427407 2026-02-24

Prospective Ultrasound Data Collection Study for AI-Based Detection of Breast Biopsy Markers

Not yet recruiting

Breast Neoplasms

NCT05022342 2026-02-23

SPEAR

Breast Neoplasms

NCT06625333 2026-02-20

PARFENOPA

Active not recruiting

HR+HER2- Advanced Breast Cancer

NCT06905301 2026-02-20

IMPULSE

Breast Neoplasms

NCT07347600 2026-02-20

reaINAVO

Breast Neoplasms

NCT04981119 2026-02-13

BASECAMP-1

BreastGastrointestinalGenitourinaryGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Mesothelioma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT04158258 2026-02-12

A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America

Active not recruiting

Breast Neoplasms

NCT06797531 2026-02-04

NISLEESA

Breast Neoplasms

NCT05054010 2026-02-02

Identification of Breast Cancer Specific Markers in Patients Compared to Healthy Participants

Active not recruiting

Breast Neoplasms

NCT06097156 2026-01-30

Evaluation of See.d as an Automated Blood Sample Preparator for Multiple Liquid Biopsy Applications

Breast Neoplasms

NCT07363434 2026-01-23

RESONATE

Breast Neoplasms, Neoplasm Metastasis

NCT06856343 2026-01-21

REBECCA

Breast Neoplasms

NCT07186296 2026-01-21

EXoPERT EMERALD Clinical Study

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms

NCT05366881 2026-01-20

CAMPERR

BreastCNSGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmPlasma cellSarcomaThoracic

Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Multiple Myeloma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT06401421 2026-01-20

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Breast Neoplasms

NCT06227728 2026-01-16

PTC-IMPACT

BreastGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Liver Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT07331506 2026-01-15

Validation of the Oncoliq Test for the Early Detection of Breast Cancer.

Breast Neoplasms

NCT07298252 2026-01-14

CARE-MMG-MRMC

Breast Neoplasms

NCT06690489 2026-01-12

BCARE

Breast Neoplasms, Skin Diseases

NCT06961331 2026-01-09

Real World-clinical Outcomes of Tucatinib, Trastuzumab, and Capecitabine Following Trastuzumab Deruxtecan (T-DXd) for the Treatment of HER2-positive Metastatic Breast Cancer.

Breast Neoplasms

NCT06672302 2026-01-08

A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients at High Risk for Breast Cancer

Breast Neoplasms, Neoplasms

NCT07327489 2026-01-08

ELEPHAS-05

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Melanoma, Neoplasms, Skin Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT04480814 2025-12-30

Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood & Primary Tumor in ER+/HER2- MBC

Breast Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT03892655 2025-12-24

LB1802

Active not recruiting

Breast Neoplasms

NCT07243002 2025-12-23

REPOWER

Breast Neoplasms

NCT04671615 2025-12-10

A Study to Understand the Treatment Patterns and Patients and Their Clinical Outcomes Who Are Taking Palbociclib in a Real Life Setting in Israel.

559 enrolled 26 charts

Breast Neoplasms

NCT04735367 2025-12-09

Study to Evaluate Overall Survival in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Letrozole

42 enrolled 7 charts

Breast Neoplasms

NCT04943497 2025-12-09

PROSPERITY

Breast Neoplasms

NCT06148506 2025-12-05

ValerEE

Active not recruiting

HR+HER2- Advanced Breast Cancer

NCT04967248 2025-12-04

A NIS of Alpelisib in Combination With Fulvestrant in Postmenopausal Women, and Men, With HR+,HER2- , Locally Advanced or Metastatic Breast Cancer With a PIK3CA Mutation, After Disease Progression Following Endocrine Therapy as Monotherapy, in the Real-world Setting

Breast Neoplasms

NCT05253911 2025-12-04

TRACE

HER2-positive Breast Cancer

NCT05006196 2025-12-01

IMOGEN

Active not recruiting

Breast Diseases, Breast Neoplasms

NCT04654208 2025-11-28

SIRI

Active not recruiting

Breast Neoplasms

NCT07076680 2025-11-28

A Real-World Study in Patients With HR+/HER2- Advanced Breast Cancer

Breast Cancer Metastatic

NCT06495164 2025-11-25

A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer

Active not recruiting

Breast Neoplasms